Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/14/2003CA2475637A1 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003CA2475493A1 Inclusion complexes of semicarbazones into cyclodetrins and uses thereof
08/14/2003CA2475447A1 Short interfering rna molecules directed towards a tissue factor coding nucleic acid
08/14/2003CA2475446A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003CA2475385A1 Hair growth promoting agent, percutaneously applied preparation, and hair growth promoting method
08/14/2003CA2475377A1 Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
08/14/2003CA2475349A1 Polyamine compounds and compositions for use in conjunction with cancer therapy
08/14/2003CA2475277A1 Method for producing recombinant proteins in micro-organisms
08/14/2003CA2475209A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003CA2475108A1 Treating benign prostate hyperplasia with sarms
08/14/2003CA2475101A1 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003CA2475093A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003CA2475066A1 Rhamnose binding protein
08/14/2003CA2475036A1 Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
08/14/2003CA2474974A1 Cytoprotective benzofuran derivatives
08/14/2003CA2474921A1 Pharmaceutical tablet
08/14/2003CA2474888A1 Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan
08/14/2003CA2474884A1 Stimulation of cpt-1 as a means to reduce weight
08/14/2003CA2474783A1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474687A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of thereof as medicaments
08/14/2003CA2474533A1 Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
08/14/2003CA2474508A1 Ansamycins having improved pharmacological and biological properties
08/14/2003CA2474431A1 Method of treating and preventing bone loss
08/14/2003CA2474424A1 Salts of valsartan
08/14/2003CA2474398A1 New immunoeffector compounds
08/14/2003CA2474283A1 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003CA2474214A1 Novel aryl- and heteroarylpiperazines
08/14/2003CA2474190A1 Pharmaceutical dosage form for mucosal delivery
08/14/2003CA2474174A1 Method for treating diseases associated with abnormal kinase activity
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003CA2474027A1 Water soluble phenylglycine derivatives
08/14/2003CA2474016A1 A combination for treating cold and cough
08/14/2003CA2473802A1 Engineering absorption of therapeutic compounds via colonic transporters
08/14/2003CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003CA2473499A1 Minrs as modifiers of insulin receptor signaling and methods of use
08/14/2003CA2473459A1 Pyridineamido derivatives as inhibitors of monoamine oxidase (mao-b)
08/14/2003CA2473212A1 Pharmaceutical composition which improves in vivo gene transfer
08/14/2003CA2473181A1 Quinoline derivatives as npy antagonists
08/14/2003CA2472249A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
08/14/2003CA2471964A1 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
08/14/2003CA2471586A1 Tumor necrosis factor combined with interferon in demyelinating diseases
08/14/2003CA2469925A1 Carnitine in the treatment of geriatric depression
08/14/2003CA2467555A1 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl)-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-me thyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/14/2003CA2466251A1 Therapeutic use of aziridino compounds
08/14/2003CA2455881A1 A stable pharmaceutical formulation comprising torsemide modification ii
08/14/2003CA2451650A1 Ligands to enhance cellular uptake of biomolecules
08/14/2003CA2450807A1 Non-myeloablative tolerogenic treatment with tyrphostins
08/13/2003EP1334973A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts
08/13/2003EP1334972A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (GnRH)
08/13/2003EP1334967A1 Process for producign optically active ethyl (3r,5s,6e)-7- 2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy-6-heptenoate
08/13/2003EP1334732A1 Pharmaceutical preparation containing copolyvidone
08/13/2003EP1334726A1 Erythromycin derivative having novel crystal structures and processes for their production
08/13/2003EP1334725A2 Estroprogestative contraceptive composition
08/13/2003EP1334724A1 Compositions for external preparations
08/13/2003EP1334723A1 Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2- 2- 4-(2-methoxyphenyl)piperazinyl]ethylamino]pyrimidine trihydrochloride as active ingredient
08/13/2003EP1334722A1 Granular drug preparations containing branched amino acids and process for producing the same
08/13/2003EP1334721A1 Nateglinide-containing hydrophilic drug preparations
08/13/2003EP1334720A1 Nateglinide-containing preparations
08/13/2003EP1334719A2 Pentafluorobenzenesulfonamides and analogs
08/13/2003EP1334718A1 Drug composition comprising dipeptydyl aldehyde derivative
08/13/2003EP1334717A2 Pharmaceutical Compositions For Oral And Topical Administration
08/13/2003EP1334716A1 Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same
08/13/2003EP1334714A1 Use of ascorbic acid to stergthen the dermal-epidermal junction
08/13/2003EP1334367A2 A method of determining the initial dose of vitamin d compounds
08/13/2003EP1334358A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334187A2 C. elegans genes involved in viability and/or reproduction and uses thereof
08/13/2003EP1334179A2 A human serpin secreted from lymphoid cells lsi-01
08/13/2003EP1334126A1 Human stra6-like protein and nucleic acids encoding the same
08/13/2003EP1334118A2 Methods and reagents for regulation of cellular responses in biological systems
08/13/2003EP1334117A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements
08/13/2003EP1334108A1 ARYL PHOSPHATE DERIVATIVES OF d4T
08/13/2003EP1334106A2 Novel imidazole derivatives, production method thereof and use thereof
08/13/2003EP1334105A1 Process for the preparation of crystalline n-formimidoyl thienamycin monohydrate (imipenem monohydrate)
08/13/2003EP1334104A2 Methods for treatment of drug-induced peripheral neuropathy and related conditions
08/13/2003EP1334103A2 Methods for treatment of disease-induced peripheral neuropathy and related conditions
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334098A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/13/2003EP1334094A1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
08/13/2003EP1334091A2 Thioflavin derivatives and their use in diagnosis and therapy of alzheimer's disease
08/13/2003EP1334090A1 Novel bicyclic isoxazolinones as antibacterial agents
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
08/13/2003EP1334087A1 Cycloalkylfluorosulfonamide derivatives
08/13/2003EP1334086A1 Phenoxyphenyl alkane sulfonates
08/13/2003EP1334085A1 Sulfamides as gamma-secretase inhibitors
08/13/2003EP1334082A2 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
08/13/2003EP1333887A2 Combination therapy comprising anti-diabetic and anticonvulsant agents
08/13/2003EP1333856A1 Modulating angiogenesis
08/13/2003EP1333855A1 Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders
08/13/2003EP1333852A2 Agents for reducing graft rejection reactions
08/13/2003EP1333848A1 Phyllanthus-derived compounds for the prevention and/or treatment of diseases associated with a retrovirus
08/13/2003EP1333845A1 Treatment of t cell disorders
08/13/2003EP1333842A2 Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
08/13/2003EP1333839A1 Method for the treatment of inflammation
08/13/2003EP1333838A2 Compounds comprising a phytosterol and/or phytostanol moiety and ascorbic acid and use thereof as weight regulating agents
08/13/2003EP1333837A1 Improved treatment
1 ... 5377 5378 5379 5380 5381 5382 5383 5384 5385 5386 5387 5388 5389 5390 5391 5392 5393 5394 5395 5396 5397 ... 7860